Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.77 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | CRHBP | P24387 | 1/20 | 0.59 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.51 |
| ▸ | CES1 | P23141 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6806851 | 1.00 | MAPK1 (0.77) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL865520 | 0.92 | LMNA (0.77) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL31174170 | 0.92 | LMNA (0.77) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL9352340 | 0.87 | LMNA (0.71) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL11714590 | 0.87 | LMNA (0.66) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL11014246 | 0.87 | MAPK1 (1.00) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL10477444 | 0.86 | LMNA (0.64) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL11025417 | 0.86 | TSHR (0.65) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL1625752 | 0.86 | LMNA (0.64) | MAPK1LMNAVCAM1MEN1KMT2A | |
| SCHEMBL10808103 | 0.86 | LMNA (0.64) | MAPK1LMNAVCAM1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116874383-A | Benzophenone LED visible light initiator and preparation method and application thereof | 贵州师范学院 | 2023-10-13 | — | — | CN | claimed |
| CN-109467512-B | Synthetic method of 3, 4-diamino-benzophenone | 苏州开元民生科技股份有限公司 | 2021-06-08 | — | — | CN | claimed |
| EP-2613819-B2 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD (GB) | 2020-11-25 | — | — | EP | claimed |
| CN-109467512-A | A kind of synthetic method of 3,4- diamino-benzophenone | 苏州开元民生科技股份有限公司 | 2019-03-15 | — | — | CN | claimed |
| CN-106083622-B | A kind of preparation method of mebendazole intermediate 3,4- diaminobenzophenones | 常州齐晖药业有限公司 | 2018-06-19 | — | — | CN | claimed |
| CN-108059602-A | A kind of preparation method of oxyclozanide intermediate 2-amino -4,6- chlorophenesic acid organic solution | 常州齐晖药业有限公司 | 2018-05-22 | — | — | CN | claimed |
| EP-2613819-B1 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD (GB) | 2018-01-10 | — | — | EP | claimed |
| CN-106083622-A | A kind of preparation method of mebendazole intermediate 3,4 diaminobenzophenone | 常州齐晖药业有限公司 | 2016-11-09 | — | — | CN | claimed |
| CN-103209717-B | Lubricious coatings for medical devices | BIOINTERACTIONS LTD | 2015-04-08 | — | — | CN | claimed |
| US-8541498-B2 | Lubricious coatings for medical devices | BIOINTERACTIONS LTD. (GB) | 2013-09-24 | — | — | US | claimed |
| EP-2613819-A1 | Lubricious coatings for medical devices | Biointeractions Ltd. (GB) | 2013-07-17 | — | — | EP | claimed |
| WO-2012032283-A1 | Lubricious coatings for medical devices | BIOINTERACTIONS LTD (GB) | 2012-03-15 | — | — | WO | claimed |
| US-20120059111-A1 | LUBRICIOUS COATINGS FOR MEDICAL DEVICES | BIOINTERACTIONS LTD. (GB) | 2012-03-08 | — | — | US | claimed |
| CN-101668425-A | Tri-aryl/heteroaroaromatic cannabinoids and use thereof | UNIV TENNESSEE RES FOUNDATION | 2010-03-10 | — | — | CN | claimed |
| US-7087641-B2 | 4β-1″-[(2″-substituted benzoyl) anilino]podophyllotoxin analogues useful as anticancer agents | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2006-08-08 | — | — | US | claimed |
| EP-1377588-B1 | 4-BETA-1''-[(2''-(SUBSTITUTED BENZOYL)ANILINO] PODOPHYLLOTOXIN ANALOGUES USEFUL AS ANTICANCER AGENTS | COUNCIL SCIENT IND RES (IN) | 2005-08-10 | — | — | EP | claimed |
| US-20050101804-A1 | 4Beta-1\"-{2'-substituted benzoyl) anilino] podophyllotoxin analogues useful as anticancer agents | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-05-12 | — | — | US | claimed |
| EP-1377588-A1 | 4-BETA-1''-[(2''-(SUBSTITUTED BENZOYL)ANILINO] PODOPHYLLOTOXIN ANALOGUES USEFUL AS ANTICANCER AGENTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-01-07 | — | — | EP | claimed |
| WO-2003082876-A1 | 4-BETA-1''-`(2''-(SUBSTITUTED BENZOYL)ANILINO! PODOPHYLLOTOXIN ANALOGUES USEFUL AS ANTICANCER AGENTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-09 | — | — | WO | claimed |
| US-4909608-A | Optical monlinearity of aminobenzophenone derivatives | MARTIN MARIETTA CORPORATION (US) | 1990-03-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101804-A1 | 4Beta-1\"-{2'-substituted benzoyl) anilino] podophyllotoxin analogues useful as anticancer agents | TUBB4A, CASP4, TUBB4B | MAPK1 3075/4885LMNA 190/4885VCAM1 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.